{
    "Trade/Device Name(s)": [
        "cobas Cdiff nucleic acid test for use on the cobas Liat System",
        "cobas Cdiff Nucleic Acid Test for use on the cobas Liat System"
    ],
    "Submitter Information": "Roche Molecular Systems, Inc.",
    "510(k) Number": "K210385",
    "Predicate Device Reference 510(k) Number(s)": [
        "K171770"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OZN",
        "OOI"
    ],
    "Summary Letter Date": "February 8, 2021",
    "Summary Letter Received Date": "February 9, 2021",
    "Submission Date": "February 9, 2021",
    "Regulation Number(s)": [
        "21 CFR 866.3130"
    ],
    "Regulation Name(s)": [
        "Clostridium Difficile Toxin Gene Amplification Assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Clostridioides difficile toxin B (tcdB) gene"
    ],
    "Specimen Type(s)": [
        "Unformed (liquid or soft) stool"
    ],
    "Specimen Container(s)": [
        "cobas PCR Media Swab Sample Kit",
        "Assay tube"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas Liat Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Silica magnetic particle-based nucleic acid extraction",
        "Multiplex assay",
        "TaqMan probe-based detection"
    ],
    "Methodologies": [
        "Nucleic acid amplification testing",
        "Sample purification",
        "Target enrichment",
        "PCR cycle threshold analysis"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Analyzer",
        "Software",
        "Specimen collection device",
        "Tube"
    ],
    "Document Summary": "FDA 510(k) summary for cobas Cdiff nucleic acid test on the cobas Liat System for qualitative detection of C. difficile toxin B gene in stool specimens using real-time PCR.",
    "Indications for Use Summary": "Automated, qualitative in vitro diagnostic test using real-time PCR for detection of toxin B (tcdB) gene of toxigenic Clostridioides difficile in unformed stool specimens from patients suspected of C. difficile infection, used as an aid in the diagnosis of CDI in conjunction with clinical and epidemiological risk factors.",
    "fda_folder": "Microbiology"
}